News Chart Psyence Biomedical Ltd.

Equities

PBM

CA74449F1009

End-of-day quote Nasdaq Other stock markets 03:30:00 27/06/2024 am IST			5-day change	1st Jan Change
0.329 ^USD	-7.53%		-11.44%	-96.44%

18/03	Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin	CI
12/03	Psyence Biomedical Ltd. Receives Human Research Ethics Committee Approval to Initiate Phase IIb Study	CI

e1c28c33865579ecacd.Eo3KZqnSP7Cp12iu-ag76NVl82Ft9-wUioCIT_anr8s.aOuoJOaWZYnYgBnKnv1hhuQ1vSUjkY4hwbPwKrPP-6V-3aQyxapywpqTLQ~cd3362fbf8ff7013cf91c5038f36b030